The immune system’s natural capacity to detect and eliminate abnormal cells may prevent the development of many cancers. However, cancer cells are sometimes able to avoid detection and destruction by the immune system through different mechanisms.

ImmunOs addresses this challenge by developing a platform technology for immunomodulatory proteins that aim to re-awake the body’s own defence system. Besides cancer, ImmunOs also explores application of their immunomodulatory binders in auto-immune diseases.